1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Hypoproteinemia: new trials by email Literature Review of Hypoproteinemia trials Research Report on Hypoproteinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome Dalteparin, Apixaban - Nephrotic Syndrome, Thromboembolic Disease | Phase 1 / Phase 2 | Completed | University of Aarhus | 57 | 2021-03-25 | 2025-04-11 |
Glomerulonephritis (1) · Glomerulonephritis, Membranous (1) · Hypoalbuminemia (1) · Nephrotic Syndrome (1) · Proteinuria (1) · Thromboembolism (1)
Autoimmune Diseases (1) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nephritis (1) · Nephrosis (1) · Pathological Conditions, Signs and Symptoms (1)
Dalteparin (1) · apixaban (1)
Denmark (1)